In a new Forbes piece, Galen Institute senior fellow and former special assistant to the president at the National Economic Council Brian Blase, discusses the ACA’s failures and how Trump administration reforms have helped. According to Blase: The Affordable Care Act (ACA), or Obamacare, was principally intended to improve health insurance markets for individuals and small … [Read more...] about How the ACA Failed–Brian Blase for Forbes
Say No To Importing Foreign Price Controls On Drugs
Grace-Marie Turner | Forbes | President Trump has doubled down on the Executive Order he put on hold in July that threatened to import price controls from countries with government-run health systems and use them as a basis for what Medicare pays for certain drugs. The new order proposes a “Most Favored Nation” (MFN) pricing scheme not only on more expensive specialty drugs paid under … [Read more...] about Say No To Importing Foreign Price Controls On Drugs
The Value Of Short-Term Health Plans: Rebutting The Energy And Commerce Democratic Staff Report
by Brian Blase and Doug Badger - Health Affairs | Although a Trump administration rule expanding Americans’ ability to benefit from short-term limited-duration insurance plans (short-term plans) was recently upheld by the District of Columbia appeals court, these plans are unpopular with many members of Congress. As such, there is a threat that the millions of people with these plans may no longer … [Read more...] about The Value Of Short-Term Health Plans: Rebutting The Energy And Commerce Democratic Staff Report
Risk adjustment is undermining ACA markets–Brian Blase in The Hill
A commonsense step to help the individual health insurance market By Brian Blase The Hill | A little-known program created by the Affordable Care Act (ACA) continues to cause problems in the individual and small group health insurance markets. The program involves shared risk payments among insurers, and it must be reformed to expand choices and lower premiums. Under the ACA, health insurers … [Read more...] about Risk adjustment is undermining ACA markets–Brian Blase in The Hill
When It Comes to COVID-19 Deaths, Florida Is No ‘New York’
July 28, 2020, The Daily Signal | Doug Badger | Deborah Birx, White House coronavirus task force head, claimed this week that “we have right now … three New Yorks,” with sharp increases in COVID-19 infections in recent weeks in Florida, Texas, and California. Incorrect. Doug Badger takes a deep dive into Florida’s numbers and finds that, despite rising cases and … [Read more...] about When It Comes to COVID-19 Deaths, Florida Is No ‘New York’
The ACA’s Risk-Adjustment Program Needs Adjusting
By Brian Blase, Ph.D. Galen Institute, July 27, 2020 | The Affordable Care Act dramatically changed insurance regulation in the individual and small-group health insurance markets. A key change detached the amount of an individual’s premium from his or her expected medical claims. By itself, this would have led to a variety of problems, including creating an incentive for … [Read more...] about The ACA’s Risk-Adjustment Program Needs Adjusting
Recommendations for Trump’s second-term health care agenda
By Brian Blase and Lanhee ChenThe Washington Times, July 22, 2020 | President Trump has an opportunity to offer a second-term agenda that builds on his administration’s successes to expand families’ control over their health care. Given the importance that Americans place on health care issues for their vote, Mr. Trump probably can’t win reelection without doing so, Blase and Chen … [Read more...] about Recommendations for Trump’s second-term health care agenda
A Health Agenda for Congress—Brian Blase in Forbes
Galen Senior Fellow Brian Blase offers recommendations for Congress on health reform, detailing four priorities Congress should enact and two prominent proposals to avoid. Here is a quick overview of his latest piece in Forbes, “What Congress Should and Should Not Do on Health Care.” Congress should: codify the Trump administration’s price transparency rulesprohibit balance … [Read more...] about A Health Agenda for Congress—Brian Blase in Forbes